1. Home
  2. VCYT vs CXT Comparison

VCYT vs CXT Comparison

Compare VCYT & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • CXT
  • Stock Information
  • Founded
  • VCYT 2006
  • CXT 1855
  • Country
  • VCYT United States
  • CXT United States
  • Employees
  • VCYT N/A
  • CXT N/A
  • Industry
  • VCYT Medical Specialities
  • CXT Office Equipment/Supplies/Services
  • Sector
  • VCYT Health Care
  • CXT Industrials
  • Exchange
  • VCYT Nasdaq
  • CXT Nasdaq
  • Market Cap
  • VCYT 2.9B
  • CXT 3.4B
  • IPO Year
  • VCYT 2013
  • CXT N/A
  • Fundamental
  • Price
  • VCYT $48.53
  • CXT $56.86
  • Analyst Decision
  • VCYT Buy
  • CXT Buy
  • Analyst Count
  • VCYT 9
  • CXT 3
  • Target Price
  • VCYT $43.56
  • CXT $75.00
  • AVG Volume (30 Days)
  • VCYT 1.2M
  • CXT 450.4K
  • Earning Date
  • VCYT 11-04-2025
  • CXT 11-05-2025
  • Dividend Yield
  • VCYT N/A
  • CXT 1.21%
  • EPS Growth
  • VCYT N/A
  • CXT N/A
  • EPS
  • VCYT 0.38
  • CXT 2.68
  • Revenue
  • VCYT $495,141,000.00
  • CXT $1,578,900,000.00
  • Revenue This Year
  • VCYT $14.52
  • CXT $9.09
  • Revenue Next Year
  • VCYT $9.90
  • CXT $7.64
  • P/E Ratio
  • VCYT $125.41
  • CXT $21.00
  • Revenue Growth
  • VCYT 16.41
  • CXT 9.30
  • 52 Week Low
  • VCYT $22.61
  • CXT $41.54
  • 52 Week High
  • VCYT $50.71
  • CXT $69.00
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 71.15
  • CXT 38.90
  • Support Level
  • VCYT $37.98
  • CXT $53.18
  • Resistance Level
  • VCYT $50.71
  • CXT $56.49
  • Average True Range (ATR)
  • VCYT 2.11
  • CXT 1.77
  • MACD
  • VCYT 0.73
  • CXT -0.30
  • Stochastic Oscillator
  • VCYT 82.09
  • CXT 35.83

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

Share on Social Networks: